Skip to content
  • donation button

Blu Genes FoundationBlu Genes Foundation
  • About Us
    • c
      • About Us
      • Blu Genes Board of Directors and Committee Members
      • Blu Genes Impact Report
      • Blu Genes 2021 Annual Report
      • Blu Genes 2022/2023 Annual Report
      • Blu Genes 2024 Annual Report
  • Genetic Disorders
    • Genetic Disorders
    • Tay-Sachs Disease
    • SPG4 Cure
  • Research & Progress
    • SickKids-Genome Editing
    • UMass-Gene Therapy
    • Gene Therapy
  • News
    • News Updates
    • Social Media
  • Events
  • Contact Us
  • Donate
  • 0

    Cart

    No products in the cart.

  • donate

Blu Genes Foundation | Archives for Chandra Ganegoda

Medical mystery: A teenager’s apparent clumsiness foreshadowed a shocking diagnosis
July 24, 2020

Judy Kalnas remembers thinking that Jessica, the youngest of her six children, resembled the elastic-limbed...

GM2 Gangliosidosis Research (Sandhoff and Tay-Sachs)
July 21, 2020

GM2 Gangliosidosis (Sandhoff and Tay-Sachs) Research Overview Sandhoff is a lysosomal storage disorder. It is...

Tay Sachs: Victorian mum with two terminally ill children tells her story
June 12, 2020

Kelly McElligott and her family. Credit: Supplied Kelly McElligott, from Victoria, is living every mother’s...

UMass Med School gene therapy shows promising early results in tackling Tay-Sachs
November 27, 2019

UMass Medical School Dean Dr. Terence R. Flotte is interviewed in his office about a...

Promising Results Reported in Tay-Sachs Gene Therapy Trial
October 29, 2019

BARCELONA – Researchers have obtained the first signs of clinical benefit in an early-stage gene...

Axovant Presents First Evidence of Clinical Stabilization in Tay-Sachs Disease at the European Society of Gene and Cell Therapy 27th Annual Congress
October 23, 2019

Initial data with AXO-AAV-GM2 suggests stabilization of disease course, attainment of normal developmental milestones, and...

Genome editing with precision
October 21, 2019

Prime editing system offers wide range of versatility in human cells, correcting disease-causing genetic variations...

$28 million grant supports Cincinnati Children’s role as coordinating center for Rare Diseases Clinical Research Network
October 4, 2019

The federal agency that oversees a large network of research centers seeking cures for hundreds...

New hope for Tay-Sachs disease at UMass Medical School
September 23, 2019

LISTEN Produced by UMass Medical School · New hope for Tay-Sachs disease A new Voices...

AXOVANT announces clinical update from first Tay-Sachs disease patient dosed with AXO-AAV-GM2 gene therapy
March 11, 2019

Generally well-tolerated with no serious adverse events in a 30-month-old patient with advanced infantile Tay-Sachs...

  • 1
  • 2

Brookfield Place, 181 Bay Street - Suite 1800
Toronto, Ontario. M5J 2T9

Tel: 647-535-GENE (4363)
Email: info@blugenes.org

  • Events
  • Gene Therapy
  • Your Impact
  • About Us
  • Genetic Disorders
  • Social Media
  • Contact Us
Copyright 2025 © BLU GENES

Blu Genes Foundation Registration # 78141 1889 RR0001

  • About Us
    • c
      • About Us
      • Blu Genes Board of Directors and Committee Members
      • Blu Genes Impact Report
      • Blu Genes 2021 Annual Report
      • Blu Genes 2022/2023 Annual Report
      • Blu Genes 2024 Annual Report
  • Genetic Disorders
    • Genetic Disorders
    • Tay-Sachs Disease
    • SPG4 Cure
  • Research & Progress
    • SickKids-Genome Editing
    • UMass-Gene Therapy
    • Gene Therapy
  • News
    • News Updates
    • Social Media
  • Events
  • Contact Us
  • Login
  • Newsletter
  • Donate

Login

Lost your password?